Literature DB >> 31742347

Unintended HIV-1 Infection During Analytical Therapy Interruption.

Ainoa Ugarte1, Yolanda Romero1, Amparo Tricas1, Concepcion Casado2, Cecilio Lopez-Galindez2, Felipe Garcia1,3, Lorna Leal1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31742347     DOI： 10.1093/infdis/jiz611

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  19 in total

1.  Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.

Authors:  Marie-Angélique De Scheerder; Clarissa Van Hecke; Henrik Zetterberg; Dietmar Fuchs; Nele De Langhe; Sofie Rutsaert; Bram Vrancken; Wim Trypsteen; Ytse Noppe; Bea Van Der Gucht; Jolanda Pelgrom; Filip Van Wanzeele; Sarah Palmer; Philippe Lemey; Magnus Gisslén; Linos Vandekerckhove
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

2.  Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria.

Authors:  Holly L Peay; Stuart Rennie; R Jean Cadigan; Angela Gwaltney; Thidarat Jupimai; Nittaya Phanuphak; Eugène Kroon; Donn J Colby; Nuchanart Ormsby; Sinéad C Isaacson; Sandhya Vasan; Carlo Sacdalan; Peeriya Prueksakaew; Khunthalee Benjapornpong; Jintanat Ananworanich; Gail E Henderson
Journal:  AIDS Behav       Date:  2022-01-08

3.  "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.

Authors:  Karine Dubé; John Kanazawa; Christopher Roebuck; Steven Johnson; William B Carter; Lynda Dee; Beth Peterson; Kenneth M Lynn; Linden Lalley-Chareczko; Emily Hiserodt; Sukyung Kim; Daniel Rosenbloom; Brad R Evans; Melanie Anderson; Daria J Hazuda; Lisa Shipley; Kevin Bateman; Bonnie J Howell; Karam Mounzer; Pablo Tebas; Luis J Montaner
Journal:  HIV Res Clin Pract       Date:  2022-03-29

4.  Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions.

Authors:  Eva M Shelton; Daniel B Reeves; Rachel A Bender Ignacio
Journal:  AIDS Rev       Date:  2020-10-26       Impact factor: 2.500

5.  Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.

Authors:  Karine Dubé; John Kanazawa; Chadwick Campbell; Cheriko A Boone; Allysha C Maragh-Bass; Danielle M Campbell; Moisés Agosto-Rosario; Jamila K Stockman; Dázon Dixon Diallo; Tonia Poteat; Mallory Johnson; Parya Saberi; John A Sauceda
Journal:  AIDS Res Hum Retroviruses       Date:  2021-05-31       Impact factor: 2.205

6.  Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.

Authors:  Marcos V P Gondim; Scott Sherrill-Mix; Frederic Bibollet-Ruche; Ronnie M Russell; Stephanie Trimboli; Andrew G Smith; Yingying Li; Weimin Liu; Alexa N Avitto; Julia C DeVoto; Jesse Connell; Angharad E Fenton-May; Pierre Pellegrino; Ian Williams; Emmanouil Papasavvas; Julio C C Lorenzi; D Brenda Salantes; Felicity Mampe; M Alexandra Monroy; Yehuda Z Cohen; Sonya Heath; Michael S Saag; Luis J Montaner; Ronald G Collman; Janet M Siliciano; Robert F Siliciano; Lindsey J Plenderleith; Paul M Sharp; Marina Caskey; Michel C Nussenzweig; George M Shaw; Persephone Borrow; Katharine J Bar; Beatrice H Hahn
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 17.956

7.  Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.

Authors:  Karine Dubé; John Kanazawa; Lynda Dee; Jeff Taylor; Danielle M Campbell; Brandon Brown; Mallory O Johnson; Parya Saberi; John A Sauceda; Jeremy Sugarman; Michael J Peluso
Journal:  HIV Res Clin Pract       Date:  2021-03-24

8.  Framing a Consent Form to Improve Consent Understanding and Determine How This Affects Willingness to Participate in HIV Cure Research: An Experimental Survey Study.

Authors:  John A Sauceda; Karine Dubé; Brandon Brown; Ashley E Pérez; Catherine E Rivas; David Evans; Celia B Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2020-12-14       Impact factor: 1.978

9.  Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.

Authors:  Karine Dubé; Shadi Eskaf; Liz Barr; David Palm; Evelyn Hogg; Jane M Simoni; Jeremy Sugarman; Brandon Brown; John A Sauceda; Laney Henley; Steven Deeks; Lawrence Fox; Rajesh T Gandhi; Davey Smith; Jonathan Z Li
Journal:  AIDS Res Hum Retroviruses       Date:  2022-04-21       Impact factor: 1.723

Review 10.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.